Citigroup Inc. (NYSE:C): Current price $48.76
Citigroup’s Treasury and Trade Solutions has expanded its Electronic Bank Account Management (eBAM) service footprint to 55 countries, bolstering Citi’s commitment to digitizing its capabilities and becoming the top digital bank on the planet. Presently, Citi eBAM is available across Europe, North America, Middle-East, Africa, and the Asia Pacific regions. This expanded worldwide presence provides increased risk management benefits to corporate treasurers and further sets Citi up as a pioneer in the eBAM marketplace.
Antares Pharma Inc. (NASDAQ:ATRS): Current price $4.72
On Monday, Antares announced the FDA approval of Otrexup injection, making it the first approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector. Otrexup is indicated for adults who have severe active rheumatoid arthritis who have had an insufficient therapeutic response to, or are intolerant of an adequate trial of first line therapy including full dose non-steroidal anti-inflammatory agents, or children with active polyarticular juvenile idiopathic arthritis.
Advanced Micro Devices Inc. (NYSE:AMD): Current price $3.98
AMD shares are up 5 percent Monday after analyst Betsy Van Hees at Wedbush upgraded the stock from Neutral to Outperform, predicting that the chip maker should finish 2013 in good form. Van Hees raised her price target to $5 from $4.50, as she said that she thinks AMD shares will trade higher as sales of new gaming consoles increase, and as business improves in the second half. The analyst commented that, “We believe AMD is back on track to deliver solid quarter-over-quarter and year-over-year earnings and revenue growth.”